GYPA and neoplasm: In this study, divalent A33scFv-Fc against GPA33 was prepared by fusing A33scFv to the Fc fragment of an hIgG1 antibody. In vitro cell binding assays demonstrated that the A33scFv-Fc produced by P. pastoris can bind GPA33-positive but not GPA-negative tumor cells.